Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Friendshoring: Pharma’s next supply chain bet?
With friendshoring gaining attention in global supply chain conversations, this story looks at what it could mean for the India…
Lupin launches Dasatinib tablets in United States
Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, in the United States, following…
Express Pharma February 2026
India's Foremost Pharma & Biotech Magazine ~ Friendshoring: Pharma's Next Supply Chain Bet?
SPARC receives Priority Review Voucher associated with Sezaby approval
Sun Pharma Advanced Research Company (SPARC) announced that the United States Food and Drug Administration (FDA) has granted a…
AstraZeneca India receives CDSCO approval for Durvalumab in combination with FLOT chemotherapy
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, announces the Central Drugs Standard Control…
Rx-to-OTC is not a channel shift—it’s a complete business model shift
By 2030, what will truly differentiate winning OTC players in India from the rest?
By 2030, the biggest differentiator for…
Uttar Pradesh gears up to showcase pharma investment opportunities at Pharma Conclave 1.0
The Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP will co-host “Pharma Conclave 1.0: Investment…
Lupin and TB Alliance collaborate to advance Telacebec for treatment of TB and other mycobacterial…
Lupin announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to advance the clinical development and…
India-EU FTA offers new hope
The signing of the India-EU Free Trade Agreement after almost two decades of negotiations is being hailed as the ‘mother of all…
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…